Regulatory News: NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN. THIS COMMUNICATION IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OF AMERICA OR ANY
Clariane : Addendum to the 2023 Universal Registration Document marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Paris, France, May 30, 2024, 7:30 pm CEST - The Combined General Meeting of shareholders of GenSight Biologics , a biopharma company focused on developing and commercializing.
Regulatory News:
Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss.
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.